학술논문
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine
Document Type
TEXT
Author
Source
Subject
Language
English
German
German